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Modeling Complex between FBA and TIM: Functional Motions of FBA and TIM are Preserved in their Complex Ataur R. Katebi, Robert L. Jernigan. Iowa State University, Ames, IA, USA. Fructuose bisphostate aldolase (FBA) and triosephosphate isomerase (TIM) are the fourth and fifth enzymes in the glycolysis pathway and they are known to bind. FBA cleaves the six-carbon fructose 1, 6-bisphosphate into two threecarbon components -dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (GAP). TIM converts DHAP into GAP, a substrate for the subsequent synthetic step. These two alpha/beta barrel proteins have high structural similarity -with a core RMSD 4.8Å . These two enzymes have low activity in the monomeric form with the functionally active structures present in higher oligomeric states. By applying Elastic Network Model, we find the modes of motions that are functionally important for these proteins. We build models for the complex between these two proteins to investigate their important motions in their complexes as well as for their different oligomeric states including those that are different in different species to learn their important modes of motions for different functionalities. For each protein, by multiple sequence alignment across the species, we predict the coevolving residues and cluster these residues along the structure. We build the information transfer pathways from the important interface residues to the catalytic residues. Change in these pathways in different oligomeric states maybe be related to the change of motions in the catalytic region in different oligomeric states. We use this knowledge about the changes in motions and the information transfer pathways within the structure of these interacting proteins as constraints for selecting the computational docked models of complexes between these two proteins to preserve their functional motions. Department of Biology, Johns Hopkins University, Baltimore, MD, USA. For several transcription factors, the same ligand can act as a positive and negative allosteric effector in a context dependent manner. The structural and molecular bases of such effects are unknown. Here it is shown that modulation of conformational fluctuations within allosteric systems can be used as a mechanism to tune protein ensembles such that a given ligand can act as both a positive and negative allosteric effector. Importantly, this mechanism can be robustly encoded in the ensemble, and does not require that the interactions between the ligand and the protein differ when it is acting either as a positive or negative effector. Instead, the effect is due to the relative probabilities of states prior to the addition of the ligand and is encoded in the thermodynamic coupling architectures between protein domains. The ensemble view of allostery that is illuminated by these studies suggests that rather than being seen as switches with fixed responses to allosteric activation, ensembles can evolve to be ''functionally pluripotent'', with the capacity to up or down regulate activity in response to a stimulus. This result not only helps to explain the prevalence of intrinsic disorder in transcription factors and other cell signaling proteins, it provides important insights about the energetic ground rules governing site-to-site communication in all allosteric systems. Kinases are one of the most intensively pursued drug targets investigated for the treatment of cancer. Kinase inhibitors usually target the ATP binding site; however, the similarity of this site across many kinases often results to non-selectivity. Therefore, allosteric modulation of kinases is of paramount importance as it may result in increased selectivity; many highly selective inhibitors have been reported to inhibit kinases by allosteric mechanisms. PI3Ka is the most frequently mutated kinase in human cancers with one of its most common mutations being a histidine changed to arginine in exon 20 (H1047R). PIK-108, a known PI3Ka inhibitor, was recently found to occupy an allosteric binding pocket in the wild type (WT) murine protein, close to the H1047R mutation. In order to assess the interactions, stability and allosteric effects of the inhibitor on PI3Ka, MD simulations in aqueous solution were performed for 130ns for the WT human, WT murine, and H1047R human mutant proteins with PIK-108 placed in both catalytic and allosteric sites. Interestingly, PIK-108 remained stable in both sites in all three variants. While in both the WT human and murine forms, the same ligand:protein interaction motifs are observed in the allosteric and catalytic pockets, these interactions are markedly different in the mutant form. In the mutant form, the allosteric pocket opens up and forms an altered hydrogen bond network with the ligand compared to the WT. Additionally, in the catalytic pocket, significant differences are evident in the interaction network formed between the inhibitor, P-loop, and the activation loop between the two protein forms. Overall, the ligand:protein interaction differences between the mutant and WT PI3Ka proteins observed in the present study provide a rich basis for the design of mutant-specific PI3Ka inhibitors. Calcium sensing receptor (CaSR), along other members of the family C G protein-coupled receptors (GPCRs), play very important roles in responding to changes in the extracellular calcium concentrations and in circulating levels of amino acids and integrating these extracellular signals into alterations in intracellular signaling pathways. However, detailed structure properties of the CaSR which are necessary to characterize the mechanism of its physiological function are still unrevealed. We have reported several potential calciumbinding sites located within the CaSR's extracellular domain using our developed computational algorithms. In the present study, we first report the differential effects of several disease-related mutations located at the predicted calcium binding sites on the inhibition and activation of intracellular calcium responses using single cell imaging. Mutating to different residues at two locations near the hinge region of the ECD could lead to either significantly lose of function of the receptor or gain of function (switch function mutations). Amino acid binding results in differential rescue effect in altering intracellular calcium responses, especially calcium oscillations.We have further probe the effect of mutation and amino acid binding on the correlation motion, cooperativity, and synergistic activation using mammalian expressed and purified 402a extracellular domain (ECD) of CaSR with various spectroscopic methods including the tryptophan fluorescence titration, circular dichroism (CD) and nuclear magnetic resonance (NMR) as well as molecular dynamic simulation. These results provide important implications for our understanding of how the CaSR integrates information about these two completely different classes of agonists-an inorganic divalent cation, and another hand, a nutrient-how the receptor senses these agonists in healthy and diseased states. Combretastatins, which are an important group of anticancer drugs,were isolated by Pettit et al. from the African tree Combretum caffrum in 1989. Additionally, Liang et al. have reported that ten coumestans were isolated fromthe roots of Hedysarum multijugum, which is a plant in Hedysarum Linn. of the family Leguminosae used as a folk herbal drug in northwest China. Coumestans comprise a class of naturally occurring products with a variety of biological activities including phytoestrogenic, antibacterial, antifungal, antimyotoxic, and phytoalexine effects. The anticancer properties of demethylwedelolactone (DWEL) and wedelolactone (WEL), which are naturally occurring coumestans, have not been well characterized. Due to their biological activities, the synthesis of DWEL is achieved in which the longest linear sequence is only eight steps in 38% overall yield from commercially available phloroglucinol. Furthmore, the molecular model was examined the interactions of proteins and ligands as well. Finally, in this study, we investigated the anti-invasive effects of synthetic WEL and DWEL on human MDA-MB-231 breast cancer cells. We found that WEL and DWEL inhibited the anchorage-independent growth and also suppressed cell motility and cell invasion of MDA-MB-231 cells. In addition, WEL and DWEL reduced the activity and expression of matrix metalloproteinases (MMPs) involved in blocking the IkB-a/NFkB and MEK/ERK signaling pathways in MDA-MB-231 cells. Furthermore, DWEL suppressed the metastasis and lung colonization of the tumor cells in the nude mice. Altogether, these data suggest that DWEL derivatives exert anti-invasive growth effect on breast cancer cells. Histone methyltransferases are enzymes that modify histone proteins via methylation of lysine or arginine residues. These epigenetic modifiers, such as DOT1L and EZH2, have been found to play important roles in leukemogenic processes. Crystallographic and docking methods studied interactions within the DOT1L binding site. Crystal structures of DOT1L also demonstrated variance in the binding mode of ligands, possibly due to rearrangement in the DOT1L binding site. We investigated this possibility by molecular dynamics (MD) simulations and confirmed significant rearrangement of the substrate binding and activation loops of DOT1L upon binding to competitive inhibitors. The druggability and volume fluctuations of the binding pocket over time were determined. The EZH2 methyltransferase is of interest due to its aberrant activity in many cancers. Because there is no published crystal structure of EZH2, we used homology modeling with homologous proteins as templates. This model provides structural information regarding the binding modes of the S-adenosyl methionine (SAM) cofactor and potential inhibitors of EZH2. Through the synergistic combination of in silico drug design, organic synthesis and biochemical assays, our modeling efforts for DOT1L and EZH2 will guide the chemical syntheses of potent and selective inhibitors of these enzymes. T cell receptors (TCRs) recognize peptides bound and presented by major histocompatibility complex (MHC) proteins using multiple complementarity determining region (CDR) loops. While numerous analyses have illuminated structural and biophysical aspects of TCR recognition, how the distribution of binding free energy within TCR-pMHC interfaces promotes unique TCR recognition features, including MHC restriction and the apparent dichotomy of specificity and cross-reactivity, remains unclear. Utilizing double mutant cycles, here we performed a comprehensive structural and thermodynamic deconstruction of the interaction between the A6 TCR and the Tax peptide presented by the class I MHC HLA-A2. In contrast with general expectations, we observed that the central regions of the peptide and its interactions with the hypervariable CDR3 loops contribute little to specificity, instead promoting by dynamic effects the cross-reactivity that is a hallmark of TCR recognition. We also observed that TCR restriction towards HLA-A2 results from not from conserved interactions with the germline loops, but instead from strong interactions with the hypervariable CDR3 loop of the a chain. Formation of these latter interactions, however, is dependent upon the unique structural properties of the peptide, highlighting that TCR specificity towards peptide and MHC can emerge from the need to engage a unique, composite peptide/ MHC interface with tightly coupled structural properties.
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Dissecting Signal Control in the Multidrug Sensor, BMRR Herschel Wade. Johns Hopkins University SOM, Baltimore, MD, USA. Multidrug (MD) (or xenobiotic) e,ux actively removes cytotoxic chemicals from the interiors of normal-functioning cells. However, high levels of e,ux can render drug-targeted cells resistant to a broad-range of therapeutic agents, including those to which cells were never exposed. Key multidrug resistance (MDR) contributors include allosteric e,ux pumps, gene regulators and other sensory systems that mediate the detection and extrusion of diverse drugs from cellular environments. To date, MDR functions remain only partially understood. Ligand-dependent allosteric control in BmrR has been quantitatively addressed using in vitro transcription experiments, dose-response curves and thermodynamic models that relate the observed transcriptional responses to ligand binding and changes in BmrR conformation. Preliminary results indicate that allosteric control in BmrR is sensitive to both energetic and structural aspects of ligand recognition. Importantly, increased cooperativity in signal control relative to recognition implicates a major allosteric role for the RNA polymerase. The active site of DHPS is comprised of three subsites: the structured ''pterin'' site, the flexible pABA site, and the anion binding pocket. Most of the drug resistant mutations have been mapped to the pABA sub-site of DHPS. using an NMR ligand-based screening approach, a number of structurally unrelated fragment-like small molecules have been identified that inhibit the enzymatic activity of DHPS from Bacillus anthracis (Ba), Yersinia pestis (Yp), and Staphylococcus aureus (Sa). Fragment hits were shown to target the three sub-pockets of the active site and a novel site distinct from the active site. The latter site potentially inhibits via an allosteric mechanism and has been characterized by high resolution X-ray crystallography. We screened the Maybridge Ò Fragment library of 1,100 fragments using water ligand observed gradient spectroscopy (waterLOGSY) as a primary screen which resulted in a hit rate of 6.7 %. Of the 74 hits, 25 were shown to inhibit DHPS activity using two independent enzyme activity assays. A total of eight compounds inhibited the activity of DHPS from three different species (Ba, Yp, and Sa). In addition to screening for inhibition, the fragment hits were validated using a number of biophysical techniques including 2D NMR, SPR, competition waterLOGSY, and X-ray crystallography. Herein, we focus on two fragment hits for which high-resolution x-ray crystal structures are available 2074-Pos Board B93 Interactomics of Blebbistatin Miklós Képiró, Boglárka H. Várkuti, György Hegyi, Mihály Kovács, András Málnási-Csizmadia. Eötvös University, Budapest, Hungary. Photoreactive molecules like aryl azides play important role in life sciences, as practical tools to achieve precisely timed covalent cross-links between ligands and targets. Since the azido group is small, stable and biologically inert,
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